Association of osteoarthritis with perfluorooctanoate and perfluorooctane sulfonate in NHANES 2003-2008

Environmental Health Perspectives

Volumn 121, Issue 4, 2013, Pages 447-452

  Uhl, Sarah A ^a   James Todd, Tamarra ^b   Bell, Michelle L ^a  

^a Yale University   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Hazardous substances; Osteoarthritis; Perfluorooctane sulfonate; Perfluorooctanoate; Public health

Indexed keywords

PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID;

ADULT; AGED; ARTICLE; EXPOSURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL STATUS; TANDEM MASS SPECTROMETRY;

ADULT; AGED; AGED, 80 AND OVER; ALKANESULFONIC ACIDS; CAPRYLATES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; FEMALE; FLUOROCARBONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; OSTEOARTHRITIS; PREVALENCE; SELF REPORT; SEX CHARACTERISTICS; TANDEM MASS SPECTROMETRY; UNITED STATES; YOUNG ADULT;

EID: 84875881481     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1205673     Document Type: Article

References (33)

1. Anderson JJ, Felson DT. 1988. Factors associated with osteo arthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work. Am J Epidemiol 128:179-189.
2. Bartell SM, Calafat AM, Lyu C, Kato K, Ryan PB, Steenland K. 2010. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect 118:222-228.
3. Betts KS. 2007. Perfluoroalkyl acids: what is the evidence telling us? Environ Health Perspect 115:A250-A256.
4. Bitton R. 2009. The economic burden of osteoarthritis. Am J Manag Care 15:S230-S235.
5. Botha-Scheepers S, Riyazi N, Kroon HM, Scharloo M, Houwing-Duistermaat JJ, Slagboom E, et al. 2006. Activity limitations in the lower extremities in patients with osteoarthritis: the modifying effects of illness perceptions and mental health. Osteoarthritis Cartilage 14:1104-1110.
6. Brede E, Wilhelm M, Göen T, Müller J, Rauchfuss K, Kraft M, et al. 2010. Two-year follow-up biomonitoring pilot study of residents' and controls' PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany. Int J Hyg Environ Health 213:217-223.
7. Calafat AM, Wong L-Y, Kuklenyik Z, Reidy JA, Needham LL. 2007. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115:1596-602.
8. CDC (Centers for Disease Control and Prevention). 2011a. About the National Health and Nutrition Examination Survey. Available: http://www.cdc.gov/nchs/nhanes/about_nhanes.htm [accessed 14 April 2012].
9. CDC (Centers for Disease Control and Prevention). 2011b. Continuous Nhanes Web Tutorial. Task 1: Specify Sampling Parameters in NHANES Using SUDAAN or SAS Survey Procedures. Available: http://www.cdc.gov/nchs/tutorials/nhanes/surveydesign/SampleDesign/intro.htm [accessed 20 April 2012].
10. CDC (Centers for Disease Control and Prevention). 2011c. Osteoarthritis. Available: http://www.cdc.gov/arthritis/basics/osteoarthritis.htm [accessed 14 April 2012]
11. DeWitt JC, Shnyra A, Badr MZ, Loveless SE, Hoban D, Frame SR, et al. 2009. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol 39:76-94.
12. Eriksen KT, Raaschou-Nielsen O, Sørensen M, Roursgaard M, Loft S, Møller P. 2010. Genotoxic potential of the perfluorinated chemicals PFOA, PFOS, PFBS, PFNA and PFHxA in human HepG2 cells. Mutat Res 700:39-43.
13. Guy WS, Taves DR, Brey WS Jr. 1976. Organic fluorocompounds in human plasma: prevalence and characterization. In: Biochemistry Involving Carbon-Fluorine Bonds (Filler R, ed). ACS Symposium Series no. 28. Washington, DC:American Chemical Society, 117-134.
14. Halldorsson TI, Rytter D, Haug LS, Bech BH, Danielsen I, Becher G, et al. 2012. Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study. Environ Health Perspect 120:668-673.
15. Innes KE, Ducatman AM, Luster MI, Shankar A. 2011. Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population. Am J Epidemiol 174:440-450.
16. Jensen AA, Leffers H. 2008. Emerging endocrine disrupters: perfluoroalkylated substances. Int J Androl 31:161-169.
17. Kato K, Wong L-Y, Jia LT, Kuklenyik Z, Calafat AM. 2011. Trends in exposure to polyfluorinated chemicals in the U.S. population: 1999-2008. Environ Sci Technol 45:8037-8045.
18. Kersten S, Desvergne B, Wahli W. 2000. Roles of PPARs in health and disease. Nature 405:421-424.
19. + homeostasis. Toxicol Appl Pharmacol 251:163-168
20. Kuklenyik Z, Needham LL, Calafat AM. 2005. Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction. Anal Chem 77:6085-6091.
21. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. 2007. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366-394.
22. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58:26-35.
23. Liu X, Jin Y, Liu W, Wang F, Hao S. 2011. Possible mechanism of perfluorooctane sulfonate and perfluorooctanoate on the release of calcium ion from calcium stores in primary cultures of rat hippocampal neurons. Toxicol In Vitro 25:1294-1301.
24. March LM, Schwarz JM, Carfrae BH, Bagge E. 1998. Clinical validation of self-reported osteoarthritis. Osteoarthritis Cartilage 6:87-93.
25. Meeker JD, Ferguson KK. 2011. Relationship between urinary phthalate and bisphenol A concentrations and serum thyroid measures in U.S. adults and adolescents from the National Health and Nutrition Examination Survey (NHANES) 2007-2008. Environ Health Perspect 119:1396-1402.
26. National Research Council. 2006. U.S. and International Biomonitoring Efforts. In: Human Biomonitoring for Environmental Chemicals (Committee on Human Biomonitoring for Environmental Toxicants, ed). Washington, DC:National Academy Press, 27-70.
27. Nelson JW, Hatch EE, Webster TF. 2010. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ Health Perspect 118:197-202.
28. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. 2007. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298-1305.
29. Qazi MR, Bogdanska J, Butenhoff JL, Nelson BD, DePierre JW, Abedi-Valugerdi M. 2009. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. Toxicology 262:207-214.
30. Qian Y, Ducatman A, Ward R, Leonard S, Bukowski V, Lan Guo N, et al. 2010. Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability. J Toxicol Environ Health A 73:819-836.
31. Singh TS, Lee S, Kim HH, Choi JK, Kim SH. 2012. Perfluorooctanoic acid induces mast cell-mediated allergic inflammaion by the release of histamine and inflammatory mediators. Toxicol Lett 210:64-70.
32. Vanden Heuvel JP, Thompson JT, Frame SR, Gillies PJ. 2006. Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-α,-β, and-γ, liver X receptor-β, and retinoid X receptor-α. Toxicol Sci 92:476-489.
33. You L, Zhu X, Shrubsole MJ, Fan H, Chen J, Dong J, et al. 2011. Renal function, bisphenol A, and alkylphenols: results from the National Health and Nutrition Examination Survey (NHANES 2003-2006). Environ Health Perspect 119:527-533.